United States Antiarthritis Market

 

Regular Price: USD 3,950

Special Price USD 2,765

30% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 2,765

PAY BY INVOICE

Be the first to review this product

Table of Contents

United States Antiarthritis Market, Executive SummaryIntroduction to the U.S. Prescription Arthritis MarketIntroduction to the U.S. Prescription Arthritis MarketObjectives and PurposeObjectives and PurposeReport Scope and SegmentationReport Scope and SegmentationReport StructureReport StructureCurrent TreatmentsCurrent TreatmentsCurrent Drug TherapiesCurrent Drug TherapiesPrevalence of Arthritis in the United StatesPrevalence of Arthritis in the United StatesSummary of Major FindingsMarket Growth, Opportunities, and Total ForecastCompetitive AnalysisStrategies for SuccessStrategies for SuccessUnited States Antiarthritis Market, Market Engineering Research MethodologyResearch ScopeObjectives and PurposeReport Structure and Market SegmentationMarket Engineering Forecasting MethodologyOverviewStrategic Significance of the Market Engineering ForecastJudging Credibility and Accuracy of Market Engineering ForecastsForecast AssumptionsGlossary of TermsList of DefinitionsList of AcronymsUnited States Antiarthritis Market, Industry ChallengesIdentification of Challenges Facing the Antiarthritis Drug MarketIdentification of Challenges Facing the Antiarthritis Drug MarketDearth of Awareness Curtails Number of Treated PatientsLack of An Efficacious and Safe Drug Diminishes Market RevenuesTowering Direct-To-Consumer Advertising Costs Limits ProfitabilitySustaining the Cut Throat Competition Abates PromotionThe Myth That Arthritis is an Untreatable Elderly Disease Confines Market GrowthPaucity of Physician Education Impedes Market PenetrationGeneric Competition Reins Prescriptions Reimbursement Issues With Managed Care Retards ExpansionLow Treatment Cost Therapies Downcast RevenuesOver-The-Counter Medications Consume Prescription SalesMarket Engineering Research for the Total U.S. Antiarthritis Market 1996-2006Market OverviewMarket OverviewDisease Overview Scope and SegmentationHistoryMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemMarket DriversMarket DriversMarket RestraintsMarket RestraintsMarket Engineering Revenue Forecasts (1996-2006)Demand AnalysisPricing AnalysisRevenuesCompetitive AnalysisCompetitive StructureCompetitive FactorsMarket Share AnalysisMarket Share Winners and WhyMarket Share Losers and WhyProduct AnalysisProducts in the MarketProducts in Clinical TrialsProducts failuresMarket Engineering Research for the U.S. Prescription Non-Steroidal Anti-Inflammatory Market 1996-2006Total Market Segment AnalysisMarket Overview DefinitionMarket Engineering Research Measurement SystemMarket Engineering Unit and Revenue Forecasts (1996-2006)Pricing Strategy and Trend AnalysisCompetitive StructureMarket Engineering Research for the U.S. Disease Modifying Anti-Rheumatic Drugs Market 1996-2006Total Market Segment AnalysisMarket Overview Definition Scope and SegmentationMarket Engineering Research Measurement SystemMarket Engineering Unit and Revenue Forecasts (1999-2006)Pricing Strategy and Trend AnalysisCompetitive StructureMarket Engineering Research for the U.S. Biological Response Modifiers Market 1996-2006Total Market Segment AnalysisMarket Overview Definition Market Engineering Research Measurement SystemMarket Engineering Unit and Revenue Forecasts (1995-2005)Pricing Strategy and Trend AnalysisCompetitive StructureAbgenixAlexion Pharmaceutical Inc.AmgenAngiotech Pharmaceuticals, Inc.AutoImmuneAxys PharmaceuticalBiogenBoston Life Sciences, Inc.Cambridge Antibody Technology Group plcCelgene Inc.CellTech GroupCentocor Inc. Connetics CorporationCorixa Inc.Genetics Institute Inc.IDEC PharmaceuticalsImmune Response Corp.Immunex Inc.Inflazyme Pharmaceuticals Ltd.Isis Pharmaceuticals, Inc.Medarex, Inc.SuperGen Inc.Valentis Inc.Vertex Pharmaceuticals Inc.United States Antiarthritis Market, Market Engineering StrategyMeasurement-Driven Strategy GenerationMarket Engineering Challenges Versus Departmental ResponsibilityMarket Drivers Versus Departmental ResponsibilityMarket Restraints Versus Departmental ResponsibilityMarket Engineering Measurement Trends Versus Departmental ResponsibilityMarket Engineering Strategic RecommendationsMarket Engineering Awards for the U.S. Antiarthritis Drugs MarketFrost & Sullivan's 2000 Market Engineering AwardsFrost & Sullivan's 2000 Market Engineering AwardsMarket Engineering AwardsMarket Engineering AwardsAward Category: Brand Awareness DevelopmentAward Category: Market Engineering Leadership – Antiarthritis Drugs MarketAward Category: Market Engineering Leadership – DMARDs MarketAward Category: Product Innovation Award Category: Product Launch Strategy




Related Research

Release Date : 21-Sep-17

Region : North America

Release Date : 21-Sep-17

Region : North America

Release Date : 21-Sep-17

Region : North America

Release Date : 21-Sep-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.